These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 7482118)

  • 1. [Large-cell anaplastic lymphomas: a genetic and immunophenotypic study].
    Martínez B; Gonzalo I; Robledo M; Benítez J; Ageitos A; Marcos B; Echezarreta G; Sanz C; Rivas C
    Sangre (Barc); 1995 Aug; 40(4):293-9. PubMed ID: 7482118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Expression of latent membrane protein (LMP) in large-cell anaplastic lymphomas].
    Gonzalo I; Santón A; Manzanal A; Marcos B; Ageitos A; Bellas C; Rivas C
    Sangre (Barc); 1995 Aug; 40(4):289-92. PubMed ID: 7482117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The interface of Hodgkin's disease and anaplastic large cell lymphoma.
    Chittal SM; Delsol G
    Cancer Surv; 1997; 30():87-105. PubMed ID: 9547988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T-cell and T/natural killer-cell lymphomas involving ocular and ocular adnexal tissues: a clinicopathologic, immunohistochemical, and molecular study of seven cases.
    Coupland SE; Foss HD; Assaf C; Auw-Haedrich C; Anastassiou G; Anagnostopoulos I; Hummel M; Karesh JW; Lee WR; Stein H
    Ophthalmology; 1999 Nov; 106(11):2109-20. PubMed ID: 10571346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Common features and differences in the transcriptome of large cell anaplastic lymphoma and classical Hodgkin's lymphoma.
    Willenbrock K; Küppers R; Renné C; Brune V; Eckerle S; Weidmann E; Bräuninger A; Hansmann ML
    Haematologica; 2006 May; 91(5):596-604. PubMed ID: 16670065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytotoxic protein expression in non-Hodgkin's lymphomas and Hodgkin's disease.
    Kanavaros P; Vlychou M; Stefanaki K; Rontogianni D; Gaulard P; Pantelidaki E; Zois M; Darivianaki K; Georgoulias V; Boulland ML; Gorgoulis V; Kittas C
    Anticancer Res; 1999; 19(2A):1209-16. PubMed ID: 10368677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anaplastic large cell lymphoma: the shifting sands of diagnostic hematopathology.
    Jaffe ES
    Mod Pathol; 2001 Mar; 14(3):219-28. PubMed ID: 11266530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Dipeptidyl aminopeptidase-IV as a histochemical marker of differential diagnosis of large cell anaplastic CD30+-lymphoma and Hodgkin's disease].
    Raĭkhlin NT; Bukaeva IA; Probatova NA; Smirnova EA; Pavlovskaia AI; Tupitsyn NN; Sholokhova EN
    Arkh Patol; 2000; 62(4):3-8. PubMed ID: 10971865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinico-morphologic reconsideration of anaplastic lymphoma. Retrospective study of 60 patients with aggressive clinical course and multiple recurrences].
    Ageitos AG; Rivas C; Lobo F; Obeso G; Marcos B; Gonzalo I; Echezarreta G; Delgado RG; Oliva H
    Rev Clin Esp; 1996 Dec; 196(12):821-7. PubMed ID: 9132858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD30-positive T-cell lymphomas co-expressing CD15: an immunohistochemical analysis.
    Gorczyca W; Tsang P; Liu Z; Wu CD; Dong HY; Goldstein M; Cohen P; Gangi M; Weisberger J
    Int J Oncol; 2003 Feb; 22(2):319-24. PubMed ID: 12527929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential expression of thymus and activation regulated chemokine and its receptor CCR4 in nodal and cutaneous anaplastic large-cell lymphomas and Hodgkin's disease.
    Vermeer MH; Dukers DF; ten Berge RL; Bloemena E; Wu L; Vos W; de Vries E; Tensen CP; Meijer CJ; Willemze R
    Mod Pathol; 2002 Aug; 15(8):838-44. PubMed ID: 12181269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The pathologic and clinical spectrum of anaplastic large cell lymphoma and correlation with ALK gene dysregulation.
    Kinney MC; Kadin ME
    Am J Clin Pathol; 1999 Jan; 111(1 Suppl 1):S56-67. PubMed ID: 9894470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [T-cell-rich B-cell lymphoma: multifactorial study of 4 cases].
    Moreno MM; Fernández-Flores A; Paradela A; Rodríguez JM; Ageitos A; Gonzalo I; Marcos B; Robledo M; Rivas C
    Sangre (Barc); 1995 Dec; 40(6):471-7. PubMed ID: 8850230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuron-specific enolase (gamma enolase, gamma-gamma dimer) expression in Hodgkin's disease and large cell lymphomas.
    Massarelli G; Onida GA; Piras MA; Marras V; Mura A; Tanda F
    Anticancer Res; 1999; 19(5B):3933-8. PubMed ID: 10628334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serous effusions in malignant lymphomas: a review.
    Das DK
    Diagn Cytopathol; 2006 May; 34(5):335-47. PubMed ID: 16604559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epstein-Bar virus and progression of non-Hodgkin's lymphoma to Ki-1-positive, anaplastic large cell phenotype.
    DiGiuseppe JA; Wu TC; Zehnbauer BA; McDowell PR; Barletta JM; Ambinder RF; Mann RB
    Mod Pathol; 1995 Jun; 8(5):553-9. PubMed ID: 7675777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. REAL classification of malignant lymphomas in the Republic of Korea: incidence of recently recognized entities and changes in clinicopathologic features. Hematolymphoreticular Study Group of the Korean Society of Pathologists. Revised European-American lymphoma.
    Ko YH; Kim CW; Park CS; Jang HK; Lee SS; Kim SH; Ree HJ; Lee JD; Kim SW; Huh JR
    Cancer; 1998 Aug; 83(4):806-12. PubMed ID: 9708949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AP1-dependent galectin-1 expression delineates classical hodgkin and anaplastic large cell lymphomas from other lymphoid malignancies with shared molecular features.
    Rodig SJ; Ouyang J; Juszczynski P; Currie T; Law K; Neuberg DS; Rabinovich GA; Shipp MA; Kutok JL
    Clin Cancer Res; 2008 Jun; 14(11):3338-44. PubMed ID: 18519761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytotoxic molecule expression is predictive of prognosis in Hodgkin's-like anaplastic large cell lymphoma.
    Asano N; Suzuki R; Matsuo K; Kagami Y; Ishida F; Tamaru JI; Jin GS; Sato Y; Shimoyama Y; Yoshino T; Morishima Y; Nakamura S
    Histopathology; 2007 May; 50(6):705-15. PubMed ID: 17493234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genomic instability and recurrent breakpoints are main cytogenetic findings in Hodgkin's disease.
    Falzetti D; Crescenzi B; Matteuci C; Falini B; Martelli MF; Van Den Berghe H; Mecucci C
    Haematologica; 1999 Apr; 84(4):298-305. PubMed ID: 10190942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.